SINGAPORE O&G LTD. Inactive Instrument
Singapore O&G Ltd. Share Price
Equities
1D8
SG1DG2000005
Healthcare Facilities & Services
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Kok Wei Choo
CEO | Chief Executive Officer | 44 | 02/02/20 |
Wai Yin Chew
DFI | Director of Finance/CFO | 49 | 30/11/18 |
Hafiza Alwi Nor
SEC | Corporate Secretary | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Siew Kin Hoon
BRD | Director/Board Member | 61 | 03/06/21 |
Boon Yew Ng
BRD | Director/Board Member | - | 31/01/18 |
Tung Lan Heng
FOU | Founder | 67 | 17/10/11 |
Singapore O&G Ltd. is a Singapore-based healthcare service provider. The Company is engaged in delivering medical services to women's and children's health and wellness. The Company operates through four segments: Obstetrics and Gynaecology (O&G), Cancer-related, Dermatology and Paediatrics. Its O&G segment relates to general obstetrics, labor and delivery, general gynecology and surgery, female pelvic medicine, urogynecology and reconstructive surgery. Its Cancer-related segment relates to medical services for gynae-oncology, breast and general surgery. Its Dermatology segment relates to the provision of aesthetic dermatological procedures, dermatologic and laser surgery and general skin care. Its Paediatrics segment relates to the provision of general pediatrics and adolescent medical services.
Calendar
07/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -12.71% | 16.73B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B |
